MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

02 Sep 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 2nd September 2021 titled ‘Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..